KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ACM Research (ACMR) EPS (Weighted Average and Diluted) (2016 - 2025)

ACM Research (ACMR) has disclosed EPS (Weighted Average and Diluted) for 10 consecutive years, with $0.21 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 54.1% to $0.21 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.21, a 86.11% decrease, with the full-year FY2025 number at $1.81, up 18.36% from a year prior.
  • EPS (Weighted Average and Diluted) was $0.21 for Q4 2025 at ACM Research, down from $0.52 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.52 in Q3 2025 to a low of -$0.09 in Q1 2022.
  • A 5-year average of $0.29 and a median of $0.3 in 2021 define the central range for EPS (Weighted Average and Diluted).
  • Peak YoY movement for EPS (Weighted Average and Diluted): plummeted 212.5% in 2022, then skyrocketed 222.22% in 2023.
  • ACM Research's EPS (Weighted Average and Diluted) stood at $0.24 in 2021, then dropped by 25.0% to $0.18 in 2022, then skyrocketed by 38.89% to $0.25 in 2023, then soared by 84.0% to $0.46 in 2024, then tumbled by 54.1% to $0.21 in 2025.
  • Per Business Quant, the three most recent readings for ACMR's EPS (Weighted Average and Diluted) are $0.21 (Q4 2025), $0.52 (Q3 2025), and $0.44 (Q2 2025).